COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

BACKGROUND: The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in guiding disease-modifying treatment (DMT). OBJECTIVE: To characterize the prevalence and outcome of COVID-19 in pwMS specifically associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Assar, Hamid, Hegen, Harald, Heschl, Bettina, Leutmezer, Fritz, Di Pauli, Franziska, Gradl, Christiane, Traxler, Gerhard, Zulehner, Gudrun, Rommer, Paulus, Wipfler, Peter, Guger, Michael, Enzinger, Christian, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315529/
https://www.ncbi.nlm.nih.gov/pubmed/34314457
http://dx.doi.org/10.1371/journal.pone.0255316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315529/
https://www.ncbi.nlm.nih.gov/pubmed/34314457
http://dx.doi.org/10.1371/journal.pone.0255316

Ejemplares similares